Contingent Negative Variation in the Evaluation of Neurocognitive Disorders Due to Possible Alzheimer’s Disease
Publisher
MDPI AG
Citation
Neurology International, 16(1), 126-138. https://doi.org/10.3390/neurolint16010008
Abstract
The usefulness of Contingent Negative Variation (CNV) potential as a biomarker of neurocognitive disorders due to possible Alzheimer’s disease, is based on its possible physiological correlates. Howev...
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Usage statistics
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
